Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,034,195
-$462,602 QoQ
Shares Held
6,599
-32.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#607
of 1,603 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HARBOUR INVESTMENTS, INC. holds $128,781,101 across 17 Drug Manufacturers - General names. NVS ranks #11 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
221,662 | $55,779,025 | |
| 2 | LLY |
ELI LILLY & Co
|
27,683 | $33,203,823 | |
| 3 | JNJ |
Johnson & Johnson
|
69,981 | $17,773,074 | |
| 4 | MRK |
Merck & Co., Inc.
|
40,366 | $5,187,031 | |
| 5 | PFE |
Pfizer Inc
|
141,011 | $3,395,544 | |
| 6 | AMGN |
Amgen Inc
|
8,295 | $3,003,785 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
50,112 | $2,887,453 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
22,237 | $2,809,422 |
All Filings in NVS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,034,195 | 6,599 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,496,797 | 9,799 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,019,824 | 7,397 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $758,667 | 5,916 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $711,901 | 5,883 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $701,320 | 6,291 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $726,419 | 7,465 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $861,959 | 7,494 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $798,343 | 7,499 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $698,970 | 7,226 | Shares | Sole | 2024-07-22 | |
| 2023-12-31 | $724,459 | 7,175 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $714,140 | 7,011 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $726,249 | 7,197 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $688,252 | 7,481 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $640,664 | 7,062 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $216,324 | 2,846 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $240,572 | 2,846 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $234,594 | 2,682 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $412,416 | 5,043 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $432,112 | 4,736 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $402,268 | 4,706 | Shares | Sole | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||